pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·2h ago·1 min read
save

Readily secures $11 million to expand AI compliance platform for insurers

Oct 13, 2026·read at Endpoints ↗DealPositive

Readily, a San Francisco‑based startup, uses artificial intelligence to monitor and flag changes in government regulations that affect insurance companies.

The company announced it has closed an $11 million financing round, according to an exclusive report from Endpoints News. The capital injection will support product development and market expansion.

With the new funds, Readily plans to enhance its compliance‑tracking tools and broaden its reach to more insurers, helping them stay up‑to‑date with evolving rules and avoid regulatory penalties.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Readily raises $11M to help insurers stay compliant”

read at Endpoints ↗
88 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 31m agoRudy Tanzi has long wanted to prevent Alzheimer's. He may be closeEndpoints
  • 31m agoBioNTech’s head and neck cancer vaccine misses first of two goalsEndpoints
  • 34m agoWhy an AI scribe wants to prescribeEndpoints
  • 4h agoParagon spins out ninth biotech, sending cardiopulmonary drugs to AlaunosEndpoints
  • 4h agoApogee execs join Paragon to scale its R&D, company creation engineEndpoints